Bioartificial liver support

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 8, Issue 1, 2001, Pages 1-15

  Hui, Thomas ^a   Rozga, Jacek ^a   Demetriou, Achilles A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioartificial liver; Hepatic encephalopathy; Liver failure

Indexed keywords

ACUTE DISEASE; ANIMAL; ARTIFICIAL LIVER; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HUMAN; LIVER CELL; LIVER FAILURE; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW;

ACUTE DISEASE; ANIMALS; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HEPATOCYTES; HUMANS; LIVER FAILURE; LIVER, ARTIFICIAL; PLASMAPHERESIS;

EID: 0035221669     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340170045     Document Type: Article

References (112)

1. Williams R (1996) Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16:343-348
2. Trey C, Davidson CS (1970) The management of fulminant hepatic failure. In: Popper H, Schaffner F (eds) Progress on liver failure. Grune and Stratton, New York, pp 292-298
3. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis: the Paul Brousse experience. Ann Surg 222:109-119
4. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, McCashland TM, Hay JE, Lee WM (1999) Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 5:86-89
5. Kiley JE, Awelch HF, Pender JC (1958) Removal of blood ammonia by hemodialysis. Proc Soc Exp Biol Med 91:489-490
6. Kiley JE, Pender JC, Welch HF, Welch CS (1937) Treatment of hepatic coma by hemodialysis. Trans Am Soc Artif Intern Organs 3:86-88
7. Shibusawa K, Tago J (1956) Artificial kidney (in Japanese). Saishin Igaku 11:298-310
8. Kono M (1959) The application of artificial kidney to acute liver failure. (in Japanese). Sogo Igaku 16:131-153
9. Silk DBA, Trewby PN, Chase RA, Mellon PJ, Hanid MA, Davies M, Langley PG, Wheeler PG, Williams R (1977) Treatment of fulminant hepatic failure by polyacrylonitrile-membrane hemodialysis. Lancet 11:1-3
10. Denis J, Opolon P, Nusinovici V, Granger A, Darnis F (1978) Treatment of encephalopathy during fulminant hepatic failure by hemodialysis with high permeability membrane. Gut 29:787-793
11. Opolon P (1979) High permeability membrane hemodialysis and hemofiltration in acute hepatic coma. Experimental and clinical results. Artif Organs 3:354-360
12. Knell AJ, Dukes DC (1976) Dialysis procedures in acute liver failure. Lancet 11:402-403
13. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R (1993) A new procedure for the removal of protein bound drugs and toxins. ASAIO J 39:621-625
14. Denis J, Opolon P, Delmore ML (1979) Long-term extracorporeal assistance by continuous hemofiltration during fulminant hepatic failure. Gastroenterol Clin Biol 3:337-348
15. Matsubara S, Okabe K, Ouchi K, Miyazaki Y, Yajima Y, Suzuki H, Otsuki M, Masaki M (1990) Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 18:1331-1338
16. Yoshiba M, Sekiyama K, Iwamura Y, Sugata F (1993) Development of a reliable artificial liver support (ALS) plasma exchange in combination with hemodiafiltration using high performance membrane. Dig Dis Sci 38:469-476
17. Yatzidis H (1966) The charcoal artificial kidney in clinical practice. Paper presented at Cleveland Clinic Foundation, Cleveland, Ohio, 18 October
18. Chang TMS (1972) Hemoperfusions over microencapsulated absorbent in a patient with hepatic coma. Lancet II:1371-1372
19. Gazzard BG, Weston MJ, Murray-Lyon IM (1974) Charcoal hemoperfusion in the treatment of fulminant hepatic failure. Lancet I:1301-1307
20. Odaka M, Tabata Y, Kobayashi H, Nomura Y, Soma H, Hirasawa H, Sato H (1978) Clinical experience of bead-shaped charcoal (hemoperfusion) in chronic renal failure and fulminant hepatic failure. In: Chang TMS (cd) Artificial kidney, artificial liver, artificial cells. Plenum. New York, pp 79-88
21. Agishi T, Yamashita N, Ota K (1980) Clinical results of direct hemoperfusion for endogenous and exogenous intoxification. In: Siedman S, Chang TMS (eds) Hemoperfusion. Part I: kidney and liver support and detoxification. Hemisphere, Washington, pp 255-263
22. Gelfand MC, Knepshield JM, Cohan S, Ramirez B, Schreiner GE (1976) Treatment of hepatic coma with hemoperfusion through polyacryamide hydrogel-coated charcoal. Kidney Int 12:239-243
23. Gimson AES, Langley PG, Hughes RD, Calanese J, Mellon PJ, Williams R, Woods HF, Weston MJ (1980) Prostacyclin to prevent platelet activation during charcoal hemoperfusion in fulminant hepatic failure. Lancet I:173-175
24. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R (1988) Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186-1192
25. Ash SR, Leamon KB, Gingrich CH (1998) Hemodiabsorption (the BioLogic-DT System) in treatment of hepatic failure with encephalopathy: summary of randomized prospectively controlled clinical trials. Poster presented at the American Association for the Study of Liver Disease. Chicago
26. Schechter DC, Nealon TF, Gibbon JH (1958) A simple extracorporeal device for reducing elevated blood ammonia levels. Surgery 44:892-897
27. Berk PD, Goldberg JK (1988) Charcoal hemoperfusion. Plus ca change, plus c'est la meme chose. Gastroenterology 94:1228-1230
28. Sabin S, Merritt JA (1968) Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann Int Med 68:1-7
29. Lepore MJ, Stutman LJ, Bonanno C, et al (1972) Plasmapheresis with plasma exchange in hepatic coma. Arch Int Med 129:900-907
30. Inoue N, Yamazaki Z, Yoshiba M, Sakai T (1981) Membrane plasmapheresis with plasma exchange in the treatment of acute liver failure. Artif Organs 5(Suppl):851-853
31. Toshiba M, Inoue N, Sanjo T, Yamazaki Z (1983) Plasmapheresis in acute liver failure. In: Nose Y, Malehesky PS, Smith JW, Krakauer RS (eds) Plasmapheresis: therapeutic applications and new techniques. Raven, New York, pp 399-406
32. Brunner G, Lasgen H (1987) Benefits and dangers of plasma exchange in patients with fulminant hepatic failure: In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis. VI. ISAO Press. Cleveland, Ohio, pp 187-191
33. Kondrup J, Almdal T, Vilstrap H, Tytgstrup N (1992) High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 15:669-676
34. Iwai H, Nagaki M, Naito T, Ishiki Y, Murakami N, Sugihara J, Muto Y, Moriwaki H (1998) Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 26:873-876
35. Burnell JM, Dawborn JK, Epstein MD, Gutman RA, Leinbach GE, Thomas ED, Volwiler W (1967) Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 276:935-943
36. Hume D, Gayle W, Williams G (1969) Cross-circulation of patients in hepatic coma with baboon partners having human blood. Surg Gynecol Obstet 128:495-517
37. Eiseman B, Liem DS, Raffucci F (1965) Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 162:329-345
38. Chari RS, Collins BH, Magee JC, CdiMaio JM, Kirk AD, Harland RC, McCann RL, Platt JL, Meyers WC (1994) Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. New Engl J Med 331:234-237
39. Sen PK, Bhalerao RA, Parulkar GP, Samsi AB, Shah BK, Kinare SG (1966) Use of isolated perfused cadaveric liver in the management of hepatic failure. Surgery 59:774-781
40. Fox IJ, Langhans AN, Fristooe LW, Shaefer MS, Vogel JE, Antonson DL, Donovan JP, Heffron TG, Markin RS, Sorrell MF, Shaw BW Jr (1993) Successful application of extracorporeal liver perfusion for the treatment of fulminant hepatic failure. A technology whose time has come. Am J Gastroenterol 88:1876-1881
41. Sorrentino F (1956) Prime ricerche per la realizzatione di un fegato artificiale. Chir Patol Sper 4:1401-1414
42. Horie M (1982) Artificial liver: the concept and working hypothesis of hybrid organs: from a 25-year-old anecdote to the 21st century model. Trans Am Soc Artif Intern Organs 28:639-641
43. Otto JJ, Pender JC, Cleary JH, Sensening DM, Welch DS (1958) The use of a donor liver in experimental animals with elevated blood ammonia. Surgery 43:301-309
44. Mikami J, Moto M, Nishimura A, Sasaki E, Nose Y, Tedo I (1959) Surgical treatment of acute liver failure II: an experimental study of extracorporeal metabolism in the artificial liver using slices of canine liver (in Japanese). Jpn J Gastroenterol 56:1022-1024
45. Nose Y, Mikami J, Kasai Y, Sasaki E, Agishi T, Danjo Y (1963) An experimental artificial liver utilizing extracorporeal metabolism with slices or granulated canine liver. Trans Am Soc Artif Intern Organs 9:358-362
46. Berry MN, Friend DS (1969) High yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study. J Cell Biol 43:466-468
47. Matsumura K (1973) Method and device for purifying blood. US Patent no. 3734851. US Patent Office, Washington DC
48. Wolf CFW, Munkelt BE (1975) Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. ASAIO Trans 21:16-26
49. Hager JC, Carmann R, Stoller R, Panol G, Ledue EG, Thayer WR, Porter LE, Galletti PM, Calabresi P (1978) A prototype for a hybrid artificial liver. ASAIO Trans 24:250-253
50. Hager JC, Carmann R, Porter LE, Galletti PM, Valabresi P (1983) Neonatal hepatocyte culture on artificial capillaries. A model for drug metabolism and artificial liver. ASAIO J 6:26-35
51. Eiseman B, Norton L, Kralios NC (1976) Hepatocyte perfusion within a centrifuge. Surg Gynecol Obstet 142:21-28
52. Olumide F, Eliashiv A, Kralios N, Norton L, Eiseman B (1977) Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer. Surgery 82:599-606
53. Soyer T, Lempinen M, Bielanski E, Eiseman B (1972) Experimental extracorporeal hepatic assist using liver slices and cell suspension. Surg Forum 23:346-348
54. Soyer T, Lempinen M, Eiseman B (1973) In vitro extracorporeal liver slices and cell suspensions for temporary hepatic support. Ann Surg 4:393-401
55. Soyer T, Lempinen M, Walker JE, Supanwanid P, Eiseman B (1973) Extracorporeal assist of anhepatic animals with liver slice perfusion. Am J Surg 126:20-24
56. Uchino J, Tsuburaya T, Kumagai F, Hase T, Hamada T, Komai T, Funatusu A, Hashimura E, Nakamura K, Kon T (1988) A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans 34:972-977
57. Matsumura KN, Guevara GR, Huston H, Hamilton WL, Rikimaru M, Yamasaki G, Matsumura MS (1987) Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 101:151-157
58. Kasai S (1986) What is needed for an artificial liver? In: Nose Y, Kjellstrand C, Ivanovich P (eds) Progress in artificial organs. ISAO Press, Cleveland, pp 711-714
59. Kasai S, Ohno M, Asakawa M, et al (1980) Studies on hybrid artificial liver - metabolic activity of isolated hepatocytes after cryopreservation. Jpn J Artif Organs 9:990-993
60. Demetriou AA, Whiting J, Levenson AM, Chowdhury NR, Schechner R, Miehalski S, Feldman D, Chowdhury JR (1986) New method of hepatocyte transplantation and extracorporeal liver support. Ann Surg 204:259-271
61. Jauregui HO, Santangini H, Naik S (1998) In vitro benzodiazepine metabolism of adult rat hepatocytes seeded in hollow-fiber membrane deviee (abstract). Hepatology 8:1387
62. Yanagi K, Ookawa K, Mizuno S (1989) Performance of a hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. ASAIO Trans 35:570-572
63. Moscioni AD, Backfish G, Bellew T, Black DL, Demetriou AA (1990) Long-term cryopreserved human hepatocytes maintain drug metabolizing ability. Surg Forum 41:3-4
64. Shatford RA, Nyberg SL, Meier SJ, White JG, Payne WD, Hu WS, Cerra FB (1992) Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res 53:549-557
65. Sussman NL, Kelly JH (1993) Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 17:27-30
66. Nyberg SL, Payne WD, Amiot B, Shirabe K, Remmel RP, Hu WS, Cerra FB (1993) Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model. Transpl Proc 25:1944-1945
67. Nyberg SL, Mann HJ, Remmel RP (1993) Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver. ASAIO Trans 39:M252-M256
68. Li AP, Barker G, Beck D, Colburn S, Monsell R, Pellegrin C (1993) Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreacter: a potential bioartificial liver. In Vitro Cell Dev Biol 29A:249-254
69. Rozga J, Lepage F, Morsiani E, Demetriou AA (1994) Liver support system development. In: Demetriou AA (ed) Support of the acutely failing liver. RG Lands, Austin TX, USA. pp 60-81
70. Fremond B, Malandain C, Guyomard C, Chesne C, Guillouzo A, Campion JP (1993) Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant 2:453-460
71. Kong SB, Chen S, Demetriou AA, Rozga J (1996) Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use. Int J Artif Organs 18:43-49
72. Bader A, Knop F, Boker K, Fruhauf N, Schuttler W, Oldhafer K, Burkhard R, Pichlmayr R, Sewing KF (1995) A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics. Artif Organs 19:368-374
73. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P (1994) Bioreactor for a large scale hepatocyte in vitro perfusion. Transplantation 59:984-988
74. Morsiani E, Pazzi P, Moscioni AD, Rozga J, Azzena G, Demetriou AA (1998) In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation. J Surg Res 79:65-60
75. Arnaoul WS, Moscioni AD, Barbour RL, Demetriou AA (1990) Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res 48:379-382
76. Shnyra A, Bocharov A, Bochkova N, Spirov V (1991) Bioartificial liver using hepatocytes on Biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats. Artif Organs 15:189-197
77. Sussman NL, Chong MG, Koussayir T, He DE, Shong TA, Whisennand HH, Kelly JH (1992) Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16:60-65
78. Takahashi T, Malchesky PS, Nose Y (1991) Artificial liver: state of the art. Dig Dis Sc 36:1327-1340
79. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio TD, Moscioni AD, Demetriou AA (1993) Hybrid bioartificial liver support treatment of animals with severe ishcemic liver failure. Ann Surg 217:502-511
80. Rozga J, Williams F, Ro MS, Neuzil D, Giorgio TD, Backfisch G, Moscioni AD, Hakim R, Demetriou AA (1993) Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17:258-265
81. Gerlach J, Trost T, Ryan CJ, Meibler M, Hole O, Muller C, Neuhaus P (1994) Hybrid liver support system in a short term application on hepatectomized pigs. Int J Artif Organs 17:549-553
82. Jauregui HO, Mullon CJ-P, Trenkler D, et al (1995) In vivo evaluation of a hollow fiber liver assist device. Hepatology 21: 460-469
83. Dixit V, Arthur M, Reinhardt R, Gitnick G (1992) Improved function of microencapsulated hepatocytes in a hybrid bioartificial liver support system. Artif Organs 16:336-341
84. Chen SC, Hewitt WR, Eguchi S, Watanabe F, Arkadopoulos N, Corno B, Suh K, Middleton Y, Rodriguez O, Kahaku E, Lane RA, Demetriou AA, Rozga J (1996) Prolonged survival in anhepatic pigs treated with a bioartificial liver. Surg Forum 47:161-163
85. Suh KS, Lilja H, Kamohara Y, Eguchi S, Arkadopoulos N, Neuman T, Demetriou AA, Rozga J (1999) Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res 85:243-250
86. Nyberg SL, Remmel RP, Mann HJ (1994) Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in bioartificial liver. Ann Surg 220:59-67
87. Gerlach J, Schnoy N, Smith MD, Nauhaus P (1994) Hepatocyte culture between woven capillary networks. A microscopic study. Artif Organs 16:226-230
88. Kim SS, Utsunomiya H, Koski JA (1998) Survival and function of hepaotcytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg 228:8-13
89. Auth MK, Okamoto M, Ishida Y, Keogh A, Auth SH, Gerlach J, Encke A, McMaster P, Strain AJ (1998) Maintained function of primary human hepatocytes by cellular interactions in coculture: implications for liver support systems. Transpl Int 11 (Suppl 1): S439-443
90. Wang S, Renaud G, Infante J, Catala D, Infante R (1985) Isolation of rat hepatocytes using EDTA and their metabolic function in primary culture. In Vitro Cell Dev Biol 21:526-530
91. Leffert H, Koch K, Moral T, Rubalcava B (1979) Hormonal control of rat liver regeneration. Gastrocntcrology 76:1470-1482
92. Miyoshi H, Yanagi K, Oshima N (1994) Long-term continuous culture of hepatocytes in a packed-bed reactor utilizing porous resin. Biotechnol Bioeng 43:635-644
93. Landry J, Bernier D, Qullet C, Goyett R, Marceau N (1985) Spheroidal aggregate culture of rat liver cells. Histotypic recognization, biomatrix deposition and maintenance of functional activities. J Cell Biol 101:914-923
94. Neuzil DF, Rozga J, Moscioni AD, Ro MS, Hakim R, Arnaout W, Demetriou AA (1993) Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 113:340-343
95. Miura Y, Akimoto T, Kanazawa H, Yagi K (1986) Synthesis and secretion of protein by hepatocytes entrapped within calcium alginate. Artif Organs 10:460-465
96. Cai Z, Shi Z, O'Shea GM, Sun AM (1988) Microencapsulated hepatocytes for bioartificial liver support. Artif Organs 12:388-393
97. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T (1987) Human liver regeneration after major hapatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 206:30-39
98. Dixit V, Darvasi R, Arthur M, Lewin K, Gitnick G (1993) Cryopreserved microencapsulated hepatocytes - transplantation studies in Gunn rats. Transplantation 55:616-622
99. Bissell MJ, Aggeler J (1987) Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? Prog Clin Biol Res 249:251-262
100. Lanford LE, Carey KD, Estlack LE, Smith GC, Hay RV (1989) Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-tree medium. In Vitro Cell Dev Biol 25:174-182
101. Goulet F, Normand C, Morin O (1988) Cellular interactions promote tissue-specific function, biomatrix deposition and junctional communication of primary cultured hepatocytes. Hepatology 8:1010-1018
102. Akimoto T, Ikeda Y, Izumi R, Kanazawa H, Okazaki M, Miura Y (1985) Fundamental studies on biological artificial liver support: liver functions of entrapped hepatocytes. Jpn J Artif Organs 14:249-252
103. Dunn JCY, Tompkins RG, Yarmush ML (1991) Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog 7:237-245
104. Koide N, Sakaguchi K, Koide Y, Asano K, Kawaguchi M, Matsushima H, Takenami T, Shinji T, Mori M, Tsuji T (1990) Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 186:227-235
105. Saito S, Sakagami K, Koide N, Morisaki F, Takasu S, Oiwa T, Orita K (1989) Transplantation of spheroidal aggregate cultured hepatocytes into rat spleen. Transplant Proc 21:2374-2377
106. Nyberg SL, Platt JL, Shirabe K, Payne WD, Hu W-S, Cerra FB (1992) Immunoprotection of xenocytes in a hollow-fiber bioartificial liver. ASAIO J 38:M463-M467
107. Li AP, Baker G, Beck D (1993) Culturing of primary hepatocytes as entrapped aggregates in a packed bed bioreactor. A potential bioartificial liver. In Vitro Cell Dev Biol 29A:249-254
108. Takahashi T, Malchesky PS, Nose Y (1991) Artificial liver. Dig Dis Sci 36:1327-1340
109. Margulis MS, Erukhimov EA, Andreiman LA, Viska LM (1989) Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency. Resuscitation 18:85-94
110. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24:1446-1451
111. Watanabe FD, Mullon CJP, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 225:484-493
112. Baquerizo A, Mhoyan A, Kearns-Jonker M, Armaout WS, Shackleton C, Busuttil RW, Demetriou AA, Cramer DV (1999) Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment. Transplant Proc 67:5-18